Literature DB >> 30190974

Radioembolization with yttrium-90 glass microspheres for patients with hepatocellular carcinoma: a review.

Jöerg Friedrich Schlaak1.   

Abstract

Clinical studies have evaluated the safety and efficacy of radioembolization with yttrium-90 in patients with unresectable hepatocellular carcinoma (HCC). Citing literature published within the last 5 years, we review the clinical evidence of survival outcomes and safety of yttrium-90 treatment in patients with unresectable HCC. This paper is primarily focused on survival rates following the typical application of yttrium-90 in HCC treatment, and also includes time to progression and safety data. Also discussed are special indications and new developments related to yttrium-90 therapy in HCC, as well as patient selection and its correlation with successful treatment outcomes.

Entities:  

Keywords:  hepatocellular carcinoma; radioembolization; yttrium-90 microspheres

Year:  2014        PMID： 30190974      PMCID： PMC6095321          DOI： 10.2217/hep.14.20

Source DB:  PubMed          Journal:  Hepat Oncol        ISSN： 2045-0923


  24 in total

Review 1.  Current strategy for staging and treatment: the BCLC update and future prospects.

Authors:  Alejandro Forner; María E Reig; Carlos Rodriguez de Lope; Jordi Bruix
Journal:  Semin Liver Dis       Date:  2010-02-19       Impact factor: 6.115

2.  Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival.

Authors:  Philip Hilgard; Monia Hamami; Amr El Fouly; André Scherag; Stefan Müller; Judith Ertle; Till Heusner; Vito R Cicinnati; Andreas Paul; Andreas Bockisch; Guido Gerken; Gerald Antoch
Journal:  Hepatology       Date:  2010-11       Impact factor: 17.425

3.  Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma.

Authors:  Riad Salem; Robert J Lewandowski; Laura Kulik; Edward Wang; Ahsun Riaz; Robert K Ryu; Kent T Sato; Ramona Gupta; Paul Nikolaidis; Frank H Miller; Vahid Yaghmai; Saad M Ibrahim; Seanthan Senthilnathan; Talia Baker; Vanessa L Gates; Bassel Atassi; Steven Newman; Khairuddin Memon; Richard Chen; Robert L Vogelzang; Albert A Nemcek; Scott A Resnick; Howard B Chrisman; James Carr; Reed A Omary; Michael Abecassis; Al B Benson; Mary F Mulcahy
Journal:  Gastroenterology       Date:  2010-10-30       Impact factor: 22.682

4.  Intra-arterial treatment with ⁹⁰Y microspheres for hepatocellular carcinoma: 4 years experience at the Ghent University Hospital.

Authors:  Bieke Lambert; Emiel Sturm; Jeroen Mertens; Ruth Oltenfreiter; Peter Smeets; Roberto Troisi; Hans Van Vlierberghe; Luc Defreyne
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-07-27       Impact factor: 9.236

5.  Radiation segmentectomy: a novel approach to increase safety and efficacy of radioembolization.

Authors:  Ahsun Riaz; Vanessa L Gates; Bassel Atassi; Robert J Lewandowski; Mary F Mulcahy; Robert K Ryu; Kent T Sato; Talia Baker; Laura Kulik; Ramona Gupta; Michael Abecassis; Al B Benson; Reed Omary; Laura Millender; Andrew Kennedy; Riad Salem
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-04-24       Impact factor: 7.038

Review 6.  Resection and liver transplantation for hepatocellular carcinoma.

Authors:  Josep M Llovet; Myron Schwartz; Vincenzo Mazzaferro
Journal:  Semin Liver Dis       Date:  2005       Impact factor: 6.115

7.  Prospective evaluation of patients with early-/intermediate-stage hepatocellular carcinoma with disease progression following arterial locoregional therapy: candidacy for systemic treatment or clinical trials.

Authors:  Khairuddin Memon; Laura Kulik; Robert J Lewandowski; Ramona Gupta; Robert K Ryu; Frank H Miller; Michael Vouche; Rohi Atassi; Daniel Ganger; Mary F Mulcahy; Riad Salem
Journal:  J Vasc Interv Radiol       Date:  2013-03-07       Impact factor: 3.464

8.  Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: a two-cohort study.

Authors:  Brian I Carr; Venkateswarlu Kondragunta; Shama C Buch; Robert A Branch
Journal:  Cancer       Date:  2010-03-01       Impact factor: 6.860

Review 9.  Yttrium 90 microspheres for the treatment of hepatocellular carcinoma.

Authors:  Khairuddin Memon; Robert J Lewandowski; Ahsun Riaz; Riad Salem
Journal:  Recent Results Cancer Res       Date:  2013

10.  Boosted selective internal radiation therapy with 90Y-loaded glass microspheres (B-SIRT) for hepatocellular carcinoma patients: a new personalized promising concept.

Authors:  E Garin; L Lenoir; J Edeline; S Laffont; H Mesbah; P Porée; L Sulpice; K Boudjema; M Mesbah; A Guillygomarc'h; E Quehen; M Pracht; J L Raoul; B Clement; Y Rolland; E Boucher
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-04-24       Impact factor: 9.236
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.